Low-dose seladelpar is an effective treatment of non-alcoholic steatohepatitis in mice with insulin resistance and metabolic dysfunction-MedSci.cn

Low-dose seladelpar is an effective treatment of non-alcoholic steatohepatitis in mice with insulin resistance and metabolic dysfunction

Azad, B; Barn, V; Haczeyni, F; Stebbins, J; Mcwherter, C; Choi, Y; Teoh, N; Farrell, G

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019; 34 (): 50

科室
- - 订阅+
  - 更多科室
工具
服务